Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

10.40USD
5:45pm BST
Change (% chg)

$-0.05 (-0.48%)
Prev Close
$10.45
Open
$10.46
Day's High
$10.49
Day's Low
$10.14
Volume
136,473
Avg. Vol
293,692
52-wk High
$20.85
52-wk Low
$9.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -1.632
FY 2018 Dec '18 0.00 -1.192
Sep '18 0.00 -0.912
Jun '18 0.00 -1.040
Mar '18 0.00 -1.733
FY 2017 Dec '17 0.94 -0.801
Sep '17 0.00 -0.923
Jun '17 0.68 -1.480
Mar '17 0.00 -1.991
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 11 0.00 0.00 0.00 5.43
Quarter Ending Dec-19 11 0.00 0.00 0.00 18.65
Year Ending Dec-19 13 0.00 0.00 0.00 25.59
Year Ending Dec-20 15 77.03 195.00 0.04 68.04
Earnings (per share)
Quarter Ending Sep-19 13 -0.94 -0.66 -1.38 -1.12
Quarter Ending Dec-19 13 -1.03 -0.78 -1.38 -0.90
Year Ending Dec-19 15 -4.45 -3.55 -5.76 -3.51
Year Ending Dec-20 15 -3.18 -1.45 -5.23 -2.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.29 34.16
P/E High - Last 5 Yrs. 96.10 166.68 54.46
P/E Low - Last 5 Yrs. 96.10 52.72 28.32
Beta 2.49 1.28 0.99
Price to Sales (TTM) -- 41.94 8.16
Price to Book (MRQ) 5.54 12.18 4.38
Price to Tangible Book (MRQ) 3.35 17.19 5.12
Price to Cash Flow (TTM) -- 64.54 24.12
% Owned Institutions -- 3.21 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.66
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.77
Payout Ratio(TTM) -- 2.08 47.42

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 65.90 14.88
Sales (TTM) vs TTM 1 Yr. Ago -100.00 47.98 8.28
Sales - 5 Yr. Growth Rate -- 33.29 9.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.81 -6.84 17.82
EPS (TTM) vs TTM 1 Yr. Ago 3.26 -- --
EPS - 5 Yr. Growth Rate -- 22.46 7.09
Capital Spending - 5 Yr. Growth Rate 74.65 26.18 7.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.77 2.53
Current Ratio (MRQ) 8.34 3.86 3.53
LT Debt to Equity (MRQ) 70.99 7.90 13.01
Total Debt to Equity (MRQ) 70.99 21.02 18.17
Interest Coverage (TTM) -- 32.44 14.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.50 50.19
Gross Margin - 5 Yr. Avg. -- 58.99 51.32
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,426.75 -11.20 16.44
Operating Margin (TTM) -- -120.61 -7.19
Operating Margin - 5 Yr. Avg. -1,440.49 -27.32 11.90
Pre-Tax Margin (TTM) -- -122.27 -7.58
Pre-Tax Margin - 5 Yr. Avg. -1,449.62 -32.37 16.01
Net Profit Margin (TTM) -- -127.93 -11.37
Net Profit Margin - 5 Yr. Avg. -1,449.62 -37.32 11.35
Effective Tax Rate (TTM) -- 17.16 20.52
Effective Tax Rate - 5 Yr. Avg. -- 18.81 24.45

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 9,538,905 868,804,616
Net Income/Employee (TTM) -1,620,456 2,084,078 101,675,245
Receivable Turnover (TTM) -- 11.95 5.90
Inventory Turnover (TTM) -- 2.41 3.66
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -58.84 6.38 10.20
Return on Assets - 5 Yr. Avg. -58.31 6.15 11.13
Return on Investment (TTM) -63.76 7.71 12.64
Return on Investment - 5 Yr. Avg. -62.41 8.01 14.10
Return on Equity (TTM) -145.22 8.16 17.19
Return on Equity - 5 Yr. Avg. -78.17 8.96 15.49
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 1.55 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Alder Biopharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.91 -13.47 23 1
13 Week -23.33 -25.81 31 17
26 Week -8.97 -20.90 46 18
52 Week -44.56 -48.36 37 6
YTD 1.95 -14.92 49 7
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 190
Total Shares Held: 91,816,537
3 Mo. Net Change: 360,348
# New Positions: 6
# Closed Positions: 3
# Increased Positions: 11
# Reduced Positions: 11
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.